Trials / Recruiting
RecruitingNCT07223164
Validation of the Masimo Irregular Heartbeat Detection Algorithm in Participants Without Cardiovascular Disease
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Masimo Corporation · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Specificity measure of performance of the Irregular Heartbeat Detection algorithm (evaluated for the finger and wrist form factors) against the Masimo Radius VSM® reference ECG. Each form factor will be evaluated independently of one another
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Masimo SET® and Masimo W1® | Pulse oximeter and wrist wearable device |
Timeline
- Start date
- 2025-10-21
- Primary completion
- 2026-06-01
- Completion
- 2026-06-01
- First posted
- 2025-10-31
- Last updated
- 2025-10-31
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07223164. Inclusion in this directory is not an endorsement.